Birchview Capital’s HOOKIPA Pharma HOOK Stock Holding History

Birchview Capital’s Portfolio HOOK Stock Details HOOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-2,000	Closed	-$183K	–	65
2021 Q2	$183K	Buy	+2,000	New	+$267K	0.11%	60

Other funds holding HOOK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Birchview Capital's HOOK Position: Q3 2021 in Review

Birchview Capital sold out of HOOKIPA Pharma (HOOK) in Q3 2021, closing a stake of 2,000 shares — an estimated $183K sold.

Birchview Capital first reported a position in HOOK in Q2 2021 and held it in 1 quarter. The position peaked at $183K in Q2 2021. 72 funds tracked by Wall St. Rank hold HOOK as of Q3 2021.

Birchview Capital reported no remaining HOOKIPA Pharma position as of Q3 2021 after selling out during the quarter.
Birchview Capital sold 2,000 HOOKIPA Pharma shares in Q3 2021, an estimated $183K.
Birchview Capital first reported a position in HOOKIPA Pharma in Q2 2021 and held it in 1 quarter.
Birchview Capital's HOOKIPA Pharma position peaked at $183K in Q2 2021.
72 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q3 2021.

Based on Birchview Capital's 13F filing for Q3 2021, filed 12 Nov 2021.